JVMRX
Price
$31.40
Change
+$0.02 (+0.06%)
Updated
Jul 31 closing price
Net Assets
23.61B
LYRBX
Price
$33.20
Change
-$0.02 (-0.06%)
Updated
Jul 31 closing price
Net Assets
1.31B
Interact to see
Advertisement

JVMRX vs LYRBX

JVMRX vs LYRBX Comparison Chart in %
View a ticker or compare two or three
VS
JVMRX vs. LYRBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Hold and LYRBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 23.6B vs. LYRBX (1.31B). JVMRX pays higher dividends than LYRBX: JVMRX (0.75) vs LYRBX (0.00). JVMRX was incepted earlier than LYRBX: JVMRX (15 years) vs LYRBX (12 years). LYRBX (1.58) is less costly to investors than JVMRX (0.75). JVMRX is a more actively managed with annual turnover of: 48.00 vs. LYRBX (32.00). LYRBX has a lower initial minimum investment than JVMRX: LYRBX (2500) vs JVMRX (1000000). LYRBX annual gain was more profitable for investors over the last year : 17.03 vs. JVMRX (8.86). LYRBX return over 5 years is better than : 56.31 vs. JVMRX (16.31).
JVMRXLYRBXJVMRX / LYRBX
Total Expense Ratio0.741.2460%
Annual Report Gross Expense Ratio0.751.5847%
Fund Existence15 years12 years-
Gain YTD14.34816.00390%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets23.6B1.31B1,796%
Annual Yield % from dividends0.750.00-
Returns for 1 year8.8617.0352%
Returns for 3 years19.2960.5932%
Returns for 5 years16.3156.3129%
Returns for 10 years63.73123.7552%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIQOX42.100.27
+0.65%
Fidelity Advisor Worldwide Z
BIAUX32.330.06
+0.19%
Brown Advisory Small-Cap Fdmtl Val Inv
GGIPX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps P
HSCCX3.10-0.01
-0.32%
Carillon Eagle Small Cap Growth C
RYBOX71.28-1.65
-2.26%
Rydex Biotechnology A